Voyager Therapeutics Company
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
(Reupload).png)
.jpg)
.png)
Technology:
Neurological Disorders
Industry:
Gene therapy
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2013
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
7
Total Funding:
135000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
13 04 15
Last Funding Type:
Series B
Register and Claim Ownership